(Q30624784)

25 June 2017

title

High relaxivities and strong vascular signal enhancement for NaGdF4 nanoparticles designed for dual MR/optical imaging (English)

1 reference

25 June 2017

6

Luce Vander Elst

1 reference

25 June 2017

Rafik Naccache

1

1 reference

25 June 2017

Pascale Chevallier

2

1 reference

25 June 2017

Jean Lagueux

3

1 reference

25 June 2017

Yves Gossuin

4

1 reference

25 June 2017

Sophie Laurent

5

1 reference

25 June 2017

Cornelia Chilian

7

1 reference

25 June 2017

John A Capobianco

8

1 reference

25 June 2017

Marc-André Fortin

9

1 reference

25 June 2017

publication date

13 May 2013

1 reference

Advanced Healthcare Materials

25 June 2017

published in

1 reference

25 June 2017

volume

2

1 reference

25 June 2017

issue

11

1 reference

25 June 2017

page(s)

1478-1488

1 reference

Strategies for increasing the sensitivity of gadolinium based MRI contrast agents

25 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Gadolinium-based hybrid nanoparticles as a positive MR contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Biodistribution study of nanometric hybrid gadolinium oxide particles as a multimodal SPECT/MR/optical imaging and theragnostic agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Renal clearance of quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Nano-sized MRI contrast agents with dendrimer cores

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

High resolution fluorescence imaging of cancers using lanthanide ion-doped upconverting nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Upconversion and anti-Stokes processes with f and d ions in solids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Monodisperse NaYbF4:Tm3+/NaGdF4 core/shell nanocrystals with near-infrared to near-infrared upconversion photoluminescence and magnetic resonance properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Core/shell NaGdF4:Nd(3+)/NaGdF4 nanocrystals with efficient near-infrared to near-infrared downconversion photoluminescence for bioimaging applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

High contrast in vitro and in vivo photoluminescence bioimaging using near infrared to near infrared up-conversion in Tm3+ and Yb3+ doped fluoride nanophosphors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Recent advances in the chemistry of lanthanide-doped upconversion nanocrystals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

An evaluation of the contributions of diffusion and exchange in relaxation enhancement by MRI contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Magnetic field dependence of solvent proton relaxation induced by Gd3+ and Mn2+ complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Coronary MR angiography: experimental results with a monomer-stabilized blood pool contrast medium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Monomer-coated very small superparamagnetic iron oxide particles as contrast medium for magnetic resonance imaging: preclinical in vivo characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Facile Synthesis of Ultrasmall and Hexagonal NaGdF4: Yb3+, Er3+ Nanoparticles with Magnetic and Upconversion Imaging Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Controlled Synthesis and Water Dispersibility of Hexagonal Phase NaGdF4:Ho3+/Yb3+Nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

Nonblinking and Nonbleaching Upconverting Nanoparticles as an Optical Imaging Nanoprobe and T1 Magnetic Resonance Imaging Contrast Agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FADHM.201300060

21 January 2018

Identifiers

DOI

10.1002/ADHM.201300060

1 reference

25 June 2017

1 reference